⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYMR News
Kymera Therapeutics, Inc. Common Stock
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
KYMR
Global Powder Metallurgy Market to Reach USD 7.68 Billion by 2032, Growing at 12% CAGR as EV Manufacturing and Sustainable Metal Processing Expand
prnewswire.com
RIO
ATI
KYMR
Form 8-K
sec.gov
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
globenewswire.com
KYMR
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
globenewswire.com
KYMR
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
globenewswire.com
KYMR